AstraZeneca hails positive results in tozorakimab lung disease trials
(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozorakimab. Read More
(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozorakimab. Read More
Metlen Energy & Metals PLC - Athens-based energy and metallurgy company - Says external auditors PricewaterhouseCoopers LLP and PricewaterhouseCoopers SA request more time to complete work on its 2025 financial statement, Metlen's first as a dual-listed entity in London and Athens. Metlen will now release of its annual results on April 9 after a nine-day delay. It confirms guidance of earnings before interest, tax, depreciation and amortisation of around GBP750 million. Read More
(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More
(Alliance News) - Food delivery company Just Eat, funeral firm Dignity and motor platform Autotrader Group PLC are among five firms under investigation by the UK's competition watchdog as part of its crackdown on fake and misleading online reviews. Read More
(Alliance News) - UK retail sales volumes fell in February after a strong start to the year, though sales remained higher over the three months, official data showed Friday. Read More
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Hires Heikki Jouttijarvi as chief technical officer, saying he has decades of experience in biopharma manufacturing, supply chain management and commercial operations. Chief Executive Officer Juho Jalkanen says: "His wealth of experience with commercial operations, manufacturing and supply chain management with late-stage and approved drugs is incredibly valuable for us as we progress with bexmarilimab to the announced phase IIb trial in higher-risk myelodysplastic syndromes". Bexmarilimab is an investigational immunotherapy designed to overcome resistance to existing treatments, among others. Myelodysplastic syndromes are a type of blood cancer. Read More
(Alliance News) - Stocks in London are set to open higher on Friday, as easing tensions in the Middle East after fresh US-Iran developments offer some relief to markets. Read More
(Alliance News) - Anheuser-Busch InBev NV announced on Friday its Chair Martin Barrington will retire at the end of next month after seven years in charge. Read More
Pan African Resources PLC - Rosebank-headquartered gold producer - Says its shareholders have approved the share capital reduction plan. The general meeting to vote on this plan was held on Thursday. The share capital reduction involves the cancellation of the Pan African's share premium account, and the "cancellation and extinguishment" of certain shares in its capital. Pan African expects the capital reduction to be effective on April 29. It expects the court hearing to confirm the capital reduction on April 28. Read More
(Alliance News) - Pay in UK retail and hospitality firms has increased by an "unprecedented" 18% in the past year, according to research. Read More
(Alliance News) - UK vehicle manufacturing fell sharply in February, an industry association reported Friday. Read More
(Alliance News) - Britain must "move away" from its reliance on the US for defence and security, members of the parliament and peers have warned amid continued transatlantic tensions. Read More
(Alliance News) - UK Prime Minister Keir Starmer has suggested US President Donald Trump's criticism of him is an attempt to push him to change his stance on the Iran war but vowed not to "buckle" under the pressure. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - BASF SE is launching an accelerated secondary placing to sell approximately 60 million ordinary shares in Harbour Energy PLC, Morgan Stanley Europe SE announced on Thursday evening. Read More